Dual agonist: GLP-1 plus GIP: Tirzapeptide is a combination of GLP-1 RA and a GIP agonist that is FDA-approved for weight loss
GLP-1s mimic a hormone produced in the gut to tamp down a persons appetite and regulate their blood sugar
Incretins and insulin sensitivity and puberty In our association analysis HOMA-IR and HOMA2-IR were both associated with GLP-1 z-score in boys and glucagon z-scores in girls
Key details Compounded GLP-1s Semaglutide injections Semaglutide microdose Semaglutide oral tablets Semaglutide oral drops Tirzepatide injections Tirzepatide oral tablets Tirzepatide oral drops Tirzepatide microdose Branded GLP-1s Ozempic Mounjaro Rybelsus Trulicity Wegovy Zepbound Saxenda/Victoza Mochi Health does not offer compounded tirzepatide in oral tablet, oral drop, or microdose formats
Notably, More recent studies suggest that PYY signaling interacts synergistically with GLP-1 and other satiety peptides, raising the possibility that lower-dose combination strategies could harness its anorectic effects while minimizing intolerance (Mentis et al., 2021
The FDA has issued warnings about unapproved GLP-1 products that may contain incorrect doses or contaminated ingredients